8-KThe WireRoutine
Reg FD Disclosure
Filed Sep 18, 2023 · 2y ago · Accession 0001558370-23-015840
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- 8-K
- Filing date
- Sep 18, 2023
- Report date
- Sep 18, 2023
- Document
- acrs-20230918x8k.htm
- Size
- 2.8 MB